-
The role of amylase-resistant starches, which are not digested in the human small intestine, as dietary therapy of various bowel diseases, such as infectious diarrhea, is not well understood.
-
-
The emergence of a new H1N1 influenza virus has triggered worldwide preparations for a pandemic.
-
On November 11, 2008, the Association for Practitioners in Infection Control and Epidemiology (APIC) announced the results of a one-day prevalence survey conducted between May and August of last year.
-
In this issue: NSAIDs in the elderly; managing GI and CVD risk with NSAIDs; low-dose naltrexone and fibromyalgia; treating glucocorticoid-induced bone loss; FDA Actions.
-
-
After acute coronary syndromes (ACS), re-currence of ischemia is a harbinger of worse prognosis.
-
New markers for a variety of diseases have recently received considerable attention, specifically B-type natriuretic peptide (BNP), N-terminal-pro-BNP, C-reactive protein, or CRP, and CRP-hs (high sensitivity). Levels of these compounds are useful guides in assessing the severity of important medical conditions, such as congestive heart failure and acute myocardial infarction chest pain.
-
Syncope is commonly accepted to be a danger sign in patients with hypertrophic cardiomyopathy (HCM). In this paper, Spirito et al report data from a registry of 1,511 patients with HCM who have been followed longitudinally at four institutions.
-
It has been postulated that angiotensin-converting enzyme (ACE) inhibitors and angiotensin II-receptor blockers (ARBs) decrease the risk of developing atrial fibrillation both indirectly by better control of hypertension and heart failure and directly by effects on fibrosis,
